| Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer. A Cercek, JC Sinopoli, J Shia, JA Weiss, L Temple, JJ Smith, LB Saltz, ... Journal of Clinical Oncology 42 (17_suppl), LBA3512-LBA3512, 2024 | 1 | 2024 |
| Hla-restricted epitopes encoded by somatically mutated genes B Vogelstein, KW Kinzler, S Zhou, L Diaz, N Papadopoulos, A Skora, ... US Patent App. 18/351,087, 2024 | | 2024 |
| Continuing the Conversation LA Diaz, LC Cantley Cancer Discovery 14 (4), 550-551, 2024 | | 2024 |
| Shotgun sequencing of serial fecal microbiome samples in patients with colorectal cancer reveals distinct bacterial species and metabolic pathways associated with tumor … M Lumish, N Waters, J Leinwand, A Saxena, A Dai, T Fei, M Fox, ... Cancer Research 84 (6_Supplement), 2805-2805, 2024 | | 2024 |
| Tumor microbial burden is regulated by mast cells and determines immunotherapy responses H Rajaei, JH Jang, H Liu, EY Faraoni, O Le Roux, V Chandra, V Tahan, ... Cancer Research 84 (6_Supplement), 6673-6673, 2024 | | 2024 |
| Hypoxia-directed treatment of human papillomavirus–related oropharyngeal carcinoma NY Lee, EJ Sherman, HK Schöder, R Wray, JO Boyle, B Singh, ... Journal of Clinical Oncology 42 (8), 940-950, 2024 | 15 | 2024 |
| Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients JR Brahmer, GV Long, O Hamid, EB Garon, RS Herbst, T Andre, ... European Journal of Cancer 199, 113530, 2024 | 5 | 2024 |
| Early identification and treatment of occult metastatic disease in stage III colon cancer (SU2C ACT3 clinical trial). L Pappas, R Yaeger, PM Kasi, MA Shah, NS Azad, NK Horick, ... Journal of Clinical Oncology 42 (3_suppl), 148-148, 2024 | 2 | 2024 |
| BRAF variants and oncogenic fusions to define sporadic MMR-deficient colorectal cancer subtypes. S Abdelfattah, G Harada, S Patel, O Artz, R Yaeger, P Johannet, E Harrold, ... Journal of Clinical Oncology 42 (3_suppl), 211-211, 2024 | | 2024 |
| Circulating mutant dna to assess tumor dynamics F Diehl, L Diaz, KW Kinzler, B Vogelstein, K Schmidt US Patent App. 18/100,301, 2024 | | 2024 |
| Methods for treating mismatch repair deficient locally advanced rectal cancer using dostarlimab L Diaz, A Cercek US Patent App. 18/325,912, 2023 | | 2023 |
| Checkpoint blockade and microsatellite instability L Diaz, B Vogelstein, KW Kinzler, N Papadopoulos, D Le, DM Pardoll, ... US Patent App. 18/224,156, 2023 | | 2023 |
| Simultaneous assessment of somatic mutations from multiple biofluids L Diaz Jr, C Stewart, S Li, J White, M Patel, E Gedvilaite, ... | | 2023 |
| VBI-S Reduces Procalcitonin in Septic Shock NSG Agayeva, M Gadiraju, M Moncure, HR Klepacz, S Benzaquen, ... JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 237 (5), S555-S555, 2023 | | 2023 |
| LBA7 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the … T Yoshino, T André, TW Kim, WP Yong, KK Shiu, BV Jensen, LH Jensen, ... Annals of Oncology 34, S1502-S1503, 2023 | | 2023 |
| 45. Clonal hematopoiesis in childhood cancer survivors I Chan, D Friedman, C Moskowitz, S Li, K Turner, J Liu, N Bouvier, ... Cancer Genetics 278, 14, 2023 | | 2023 |
| 2235P Chemotherapy priming leads to hypermutability and immune surveillance in colorectal cancer PP Vitiello, R Chilà, P Battuello, V Battaglieri, V Amodio, G Grasso, ... Annals of Oncology 34, S1151, 2023 | | 2023 |
| LBA32 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the … KK Shiu, T André, TW Kim, BV Jensen, LH Jensen, CJA Punt, D Smith, ... Annals of Oncology 34, S1271-S1272, 2023 | 6 | 2023 |
| Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade EC Harrold, MB Foote, B Rousseau, H Walch, Y Kemel, AL Richards, ... Nature Medicine 29 (10), 2458-2463, 2023 | 5 | 2023 |
| Favorable Survival after Definitive Ablative RT in Surgically Resectable Pancreatic Cancer Patients M Reyngold, E O'Reilly, M Zinovoy, C Hajj, AJ Wu, J Cuaron, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e335, 2023 | | 2023 |
Bert VogelsteinJohns Hopkins在 jhmi.edu 的电子邮件经过验证
